Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2012 | 09-2012 | 06-2012 | 12-2011 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -11,630 | -7,431 | -4,794 | -3,460 |
| Depreciation Amortization | 10 | 7 | 5 | 4 |
| Accounts payable and accrued liabilities | N/A | 142 | -210 | N/A |
| Other Working Capital | 2,200 | 2,432 | 1,159 | 290 |
| Other Operating Activity | 1,610 | -56 | 240 | 26 |
| Operating Cash Flow | $-7,810 | $-4,906 | $-3,600 | $-3,140 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -10 | -7 | -2 | -20 |
| Purchase Of Investment | N/A | -2,952 | 1,972 | N/A |
| Sale Of Investment | N/A | 2,952 | -1,972 | N/A |
| Other Investing Activity | -1,000 | 0 | 0 | -6,520 |
| Investing Cash Flow | $-1,010 | $-7 | $-2 | $-6,540 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | N/A | 177 | N/A | N/A |
| Other Financing Activity | 16,790 | 7,699 | 7,699 | 7,540 |
| Financing Cash Flow | $16,790 | $7,876 | $7,699 | $7,540 |
| Beginning Cash Position | 6,000 | 6,002 | 6,002 | 8,150 |
| End Cash Position | 13,970 | 8,965 | 10,099 | 6,000 |
| Net Cash Flow | $7,970 | $2,963 | $4,097 | $-2,140 |
| Free Cash Flow | ||||
| Operating Cash Flow | -7,810 | -4,906 | -3,600 | -3,140 |
| Capital Expenditure | N/A | -7 | -2 | N/A |
| Free Cash Flow | -7,810 | -4,913 | -3,602 | -3,140 |